Transferator (TRAN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
6 Jun, 2025Executive summary
Revenue for 2024 was 55.2 MSEK, down 10% year-over-year, mainly due to weak demand in construction and related sectors amid a broad economic downturn.
EBITDA for the year fell 40% to 4.4 MSEK, reflecting lower sales and continued high financial costs from interest and currency losses.
Net income rose to 36.8 MSEK, significantly boosted by additional earn-outs from the sale of ELKAB Studios AB shares.
All revenue is attributed to the ABG group, with energy storage solutions demand supported by geopolitical events.
Investments focused on rental assets within ABG and financial holdings, including Q-linea AB.
Financial highlights
Full-year revenue: 55.2 MSEK (60.9 MSEK in 2023); Q4 revenue: 16.4 MSEK (21.3 MSEK in Q4 2023).
Full-year EBITDA: 4.4 MSEK (7.3 MSEK in 2023); Q4 EBITDA: 2.4 MSEK (4.1 MSEK in Q4 2023).
Net income for 2024: 36.8 MSEK (21.6 MSEK in 2023); Q4 net income: 2.3 MSEK (0.2 MSEK in Q4 2023).
Financial income and costs for 2024: 37.5 MSEK (20.2 MSEK in 2023).
Cash flow for the year: 16.9 MSEK (outflow of 4.7 MSEK in 2023); cash at year-end: 17.9 MSEK.
Segment performance
ABG group: All group revenue derived from ABG, which leads the Swedish market in fuel tank rental and sales; demand impacted by low construction activity.
E-Ply: Production paused; future investment plan under consideration.
Ventures: Earn-outs from ELKAB Studios AB contributed significantly to results; portfolio includes minority stakes in Hedera Group, EMPE Diagnostics, and Q-Linea.
Latest events from Transferator
- Stable revenue, weak Q4, one-time gain lifts profit, no dividend for 2025.TRAN
Q4 202527 Feb 2026 - Revenue up, net income flat; sector weakness offset by other segments, Q-Linea loss weighs.TRAN
Q3 202529 Nov 2025 - Stable sales and EBITDA, but net profit fell sharply without last year’s one-off gains.TRAN
Q2 202529 Aug 2025 - Q3 net loss driven by Hedera write-downs, but nine-month profit rose on ELKAB earn-outs.TRAN
Q3 202413 Jun 2025 - Net income rose sharply to 39.4 MSEK, with improved equity ratio and strong liquidity.TRAN
Q2 202413 Jun 2025 - Stable operations but net loss in Q1 2025 as one-time gains were not repeated.TRAN
Q1 20256 Jun 2025